Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans

Acta Neurologica Scandinavica

Volumn 112, Issue 5, 2005, Pages 317-322

  Alaez C ^a   Corona, T ^b   Ruano, L ^b   Flores, H ^a,c   Loyola, M ^a   Gorodezky, Clara ^a  

^a Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Genetic susceptibility; Human leukocyte antigen; Major histocompatibility complex class II alleles; Multiple sclerosis; Predisposition

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HISPANIC; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; SEX RATIO;

ADOLESCENT; ADULT; ALLELES; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HOMOZYGOTE; HUMANS; INDIANS, CENTRAL AMERICAN; MALE; MEDITERRANEAN REGION; MEXICO; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 27444443601     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00493.x     Document Type: Article

References (42)

1. HOGANCAMP WE, NOSEWORTHY JH. Demyelinating disorders of the central nervous system. In: Goetz ChC, Pappert EJ, eds. Textbook of clinical neurology. Philadelphia, PA: Saunders, 1999; 970-89.
2. VITALE E, COOK S, SUN R et al. Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12. Hum Mol Genet 2002;11:295-300.
3. ELIAN M, NIGHTINGALE S, DEAN G. Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies. J Neurol Neurosurg Psychiatry 1990;53:906-11.
4. WYN DR, RODRIGUEZ M, O'FALLON WM, KURLAND LT. A reappraisal of the epidemiology of multiple sclerosis in Olmsted Country, Minnesota. Neurology 1990;40:780-6.
5. BAN M, STEWART GJ, BENNETTS BH et al. A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun 2002;3:464-9.
6. AKESSON E, OTURAI A, BERG J et al. A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun 2002;3:279-85.
7. SAWCER S, JONES HB, FEAKES R et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996;13:464-8.
8. DAYMENT DA, SADOVNICK AD, WILLER JC et al. An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: a report from the Canadian Collaborative study group. Hum Mol Genet 2004;13:1005-12.
9. CORADDU F, SAWCER S, D'ALFONSO S et al. A genome screen for multiple sclerosis in Sardinian multiplex families. Eur J Hum Genet 2001;9:621-6.
10. NAITO S, KUROIWA Y, ITOYAMA T et al. HLA and Japanese MS. Tissue Antigens 1978;12:19-24.
11. JERSILD C, FOG, T, HANSEN GS, THOMSEN M, SVEJGAARD A, DUPONT B. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 1973;2:1221-5.
12. HOGANCAMP WE, RODRIGUEZ M, WEINSHENKER BG. Identification of multiple sclerosis-associated genes. Mayo Clin Proc 1997;72:965-76.
13. MILLER DH, HORNABROOK RW, DAGGER J, FONG R. Class II HLA antigens in multiple sclerosis. J Neurol Neurosurg Psychiatry 1989;52:575-7.
14. LIBLAU R, VAN ENDERT PM, SANDBERG-WOLLHEIM M et al. Antigen processing gene polymorphisms in HLA-DR2 multiple sclerosis. Neurology 1993;43:1192-7.
15. KURDI A, AYESH I, ABDALLAT A, MAAYTA U. Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and North Europeans. Lancet 1977;1:1123-5.
16. HAO Q, SAIDA T, KAWAKAMI H et al. HLAs and genes in Japanese patients with multiple sclerosis: evidence for increased frequencies of HLA-Cw3, HLA-DR2, and HLA-DQB1*0602. Hum Immunol 1992;35:116-24.
17. KIRA J, KANAI T, NISHIMURA Y et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996;40:569-74.
18. KIRA J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003;2:117-27.
19. SADOVNICK AD, BAIRD PA, WARD RH. Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988;29:533-41.
20. SADOVNICK AD, EBERS GC. Genetics of multiple sclerosis. Neurol Clin 1995;13:99-118.
21. MARROSU MG, MUNTONI F, MURRU MR et al. Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurology 1988;38:1749-53.
22. ALVES-LEON SV. HLA DQB1*0602 confere susceptibilidade genética para esclerose múltipla numa populaçâo de pacientes Afro-Brasileiros da cidade do Rio de Janeiro. PhD Thesis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, 1999.
23. PAPAIS-ALVARENGA R, ALVES-LEON SV, CABALLERO A, ALONSO A, FERNANDEZ O. DR2 haplotype confers genetic susceptibility to multiple sclerosis in white Brazilian patients. Communication. XIX Brazilian Congreso of Neurology, Salvador, 2000.
24. GORODEZKY C, NAJERA R, RANGEL BE et al. Immunogenetic profile of multiple sclerosis in Mexicans. Hum Immunol. 1986;16:364-7.
25. CORONA T, RODRIGUES JL, STOPP L. Multiple sclerosis in Mexico: hospital cases at the National Institute of Neurology and Neurosurgery, Mexico City. Neurologia 1996;11:170-3.
26. GONZALEZ O, SOTELO J. Is the frequency of multiple sclerosis increasing in Mexico? J Neurol Neurosurg Psychiatry 1995;59:528-30.
27. ALVARADO-DE LA BARRERA C, ZUNIGA-RAMOS J, RUIZ-MORALES JA, ESTANOL B, GRANADOS J, LLORENTE L. HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis. Neurology 2000;26:1897-900.
28. MIRSATTARI SM, JOHNSTON JB, MCKENNA R et al. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology 2001;56:317-23.
29. YAMASAKI K, HORIUCHI I, MINOHARA M et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 1999;122:1689-96.
30. POSER CM, PATY DW, SCHEINBERG L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
31. KURTZKE JF. Rating neurological impairment in multiple sclerosis: an expanded disability scale status. Neurology 1983;33:1444-52.
32. GORODEZKY C. Genetic differences between European and Indians: tissue and blood types. Allergy Proc 1992;13:243-53.
33. BIGNON JD, FERNANDEZ-VIÑA MA, CHENEAU ML et al. HLA DNA class II typing by PCR-SSOP: 12th International Workshop Experience. In: Charron D, ed. Genetic diversity of HLA. Functional and medical implication, Vol. I. Paris: EDK, 1997:21-5.
34. MARSH SG, BODMER JG, ALBERT ED et al. Nomenclature for factors of the HLA system, 2002. Hum Immunol 2002;63:1213-28.
35. ZETTERQUIST H, BENGTSSON M, BACKSTROM G et al. Report from the HLA class II typing by PCR-SSP Multicentre study. Eur J Immunogenet 1997;241:191-9.
36. HALDANE JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956;20:309-11.
37. SCHNEIDER S, ROESSLI D, EXCOFFIER L. Arlequin V2.0: a software for population genetic data analysis. Switzerland: Genetics and Biometry Laboratory, University of Geneva, 1999.
38. URIA DF. HLA and multiple sclerosis studies of a Spanish population. Rev Neurol 2000;31:1066-75.
39. COMPSTON A. Distribution of multiple sclerosis. In: Compston A ed. McAlpine's multiple sclerosis. London: Churchill Livingstone, 1998;63-100.
40. VAZQUEZ-GARCIA MN, ALAEZ C, OLIVO A et al. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Hepatol 1998;28:985-90.
41. FINN TP, JONES RE, RICH C et al. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes. J Neurosci Res 2004;78:100-14.
42. WEKERLE H, HOHLFELD R. Molecular mimicry in multiple sclerosis. N Engl J Med 2003;349:185-6.